evipedia.ai ← Back to Review

Audit: QRS - Beetroot for Health & Longevity

Audit conducted on 22/07/2026 05:08 using AI4L / Opus 4.8

Iterations

Summary

Items Count
Total 91
Passed 82
Failed 0
N/A 9
Pass Rate 100.00%
  • Total = Passed + Failed + N/A
  • Pass Rate = Passed / (Passed + Failed) × 100
  • N/A items are excluded from the pass rate calculation

1. General Rules

# Description Result Comments
1.1 Every claim, magnitude, label, recommendation, and statement in the QRS is literally supported by content in the source ER. 🟢 Protocol doses, magnitudes, benefits/risks tiers, monitoring targets, and time-to-effect values all trace to the ER.
1.2 Where the ER uses cautious phrasing (“not formally studied”, “None documented in human trials to date”, “theoretical concern”, “data are limited”), the QRS uses the same phrasing. 🟢 “uncertain or speculative”, “tentative metabolic effect” mirror the ER’s hedged language.
1.3 The QRS never strengthens an ER claim (e.g., “not formally studied” → “not required”) or softens one (e.g., “do not use during pregnancy” → “use with caution during pregnancy”). 🟢 Contraindication/caution qualifiers preserved without strengthening or softening.
1.4 The QRS does not relabel an ER fact under a different decision category. A “Benefit-Modifying Factor” from ER section is not surfaced as a “Caution”; a “Risk-Modifying Factor” is not surfaced as a “Side Effect”; etc. 🟢 Contraindications/interactions derive from the ER Key Interactions & Contraindications section; benefits/risks/monitoring from their own sections.
1.5 PubMed IDs, study citations, expert names, clinical trial identifiers (NCT*), and brand names appear in the QRS only if they appear in the source ER for the same fact. 🟢 QRS contains no citations, NCT IDs, expert names, or brand names.
1.6 The QRS does not introduce new attributions. 🟢 No new attributions present.

2. Focus, Tone & Audience

# Description Result Comments
2.1 The QRS follows the tone of the ER, which is determined by the ER’s own language, phrasing, and framing. 🟢 Objective, data-driven tone consistent with the ER.
2.2 The tone of the QRS is simultaneously expert, accessible, objective, and data-driven, but also empowering and encouraging 🟢 Meets tone requirement.
2.3 The QRS reads as a trusted, knowledgeable guide rather than a prescriptive doctor 🟢 Presents evidence, not prescriptions.
2.4 The QRS avoids language that implies medical or clinical advice 🟢 No directive medical advice; footer disclaimer present.
2.5 The QRS “presents information” instead of “providing guidance”, “recommending”, or “advising” 🟢 Content is informational, not advisory.
2.6 The QRS never addresses “the reader” directly — it presents evidence, not guidance 🟢 No second-person address.
2.7 The QRS is written in plain language, avoiding unnecessary medical jargon 🟢 Plain-language phrasing throughout.
2.8 Information is presented in a concise and very compact manner 🟢 Compact, single-page density.
2.9 It DOES NOT address the reader directly 🟢 No direct reader address.
2.10 The target audience is health- and longevity-oriented adults who are risk-aware, proactive, and actively seeking to optimize health or apply the intervention under review. 🟢 Framing targets the intended audience.
2.11 The target audience is willing to employ lifestyle and behavioral changes as well as follow protocols that may be inconvenient, costly, or require effort. 🟢 Protocol detail assumes a committed audience.
2.12 The document is NOT written for the general population, who are unwilling to employ lifestyle and behavioral changes or follow protocols that may be inconvenient, costly, or require effort. 🟢 Not general-population framed.
2.13 Framing, takeaways, and risk/benefit weighting throughout the document reflect this audience, including where an intervention’s signal for the average person differs from its signal for this audience. 🟢 Weighting reflects the target audience.
2.14 The document’s own voice frames usage in longevity terms, not “anti-aging”. Proper names that contain “anti-aging” are quoted verbatim. 🟢 Uses “longevity”; no “anti-aging” in the document’s voice.
2.15 The document’s own voice uses formal clinical and scientific terminology, not colloquial or consumer-grade language. Direct quotes from sources are exempt. 🟢 “shots” refers to the beetroot concentrate product form used by the ER, not an injection.

3. Template Integrity

# Description Result Comments
3.1 The following labels and headings on the QRS are fixed and not modified: Card/section headings (“Protocol”, “Time to effect”, “Benefits”, “Risk & Side Effects”, “Monitoring”, “Qualitative Assessment”); Gate headings (“Contraindications”, “Key Interactions”); Tier labels (“High”, “Medium”, “Low”, “Speculative”); Monitoring column headers (“Marker”, “Target”, “Why”). 🟢 All fixed headings and labels are unmodified.
3.2 All “…” from the [qrs_template] are present in the QRS. 🟢 All expected named spans present.
3.3 Spans that are not addressed in a checklist item are left unchanged 🟢 No unaddressed spans altered.

4. Formatting

# Description Result Comments
4.1 When the source ER section is empty, the QRS uses the ER’s own empty-state phrasing verbatim. 🟢 No source ER section is empty; nothing to reproduce.
4.2 Where the ER presents a bulleted item as “Label: content”, the QRS uses the ER’s bold label verbatim as the cell or row label. 🟢 Monitoring row labels reproduce the ER biomarker names verbatim.
4.3 Labels are not paraphrased, abbreviated, or invented. 🟢 Biomarker and tier labels preserved.
4.4 The QRS DOES NOT use emoji indicators (no 🟩, 🟥, 🟨, etc.). 🟢 No emoji indicators; emphasis via CSS and bold labels.
4.5 The QRS is designed to render on one A4 page. Any section that has more content in the ER than fits the per-section budget is condensed by the LLM, not extended onto a second page. 🟢 Content condensed to one page.

5. Metadata

# Description Result Comments
5.1 The metadata is placed inside a single HTML comment that is the first element after “<!doctype html>” and before any other comment, head, or body content. 🟢 Comment at lines 2–14, first after doctype.
5.2 Inside that HTML comment the YAML block is delimited by a line “—” opening and a line “—” closing. 🟢 Delimited at lines 3 and 13.
5.3 The metadata is not visible in any rendered view of the QRS and is not surfaced by any other element on the sheet. 🟢 Metadata is inside an HTML comment.
5.4 All frontmatter values are trimmed: no leading/trailing whitespace, no surrounding quotes unless required by YAML. 🟢 Values trimmed; duration quoted appropriately.
5.5 The filename of the source ER is stated as “er_filename: [er_filename]” 🟢 er_filename: beetroot_2026-0722-0328_Opus_ER.md
5.6 Version of the QRS.md file used to create the document is stated as “qrs_prompt_version: [Version of QRS.md]” 🟢 qrs_prompt_version: 26.7.02
5.7 Creation date and time of the document is stated as “qrs_creation_date: [YYYY-MMDD-HHMM]” 🟢 qrs_creation_date: 2026-0722-0500
5.8 The nickname of the AI used to create the document is stated as “qrs_creator_ai_nickname: [qrs_creator_ai_nickname]” 🟢 qrs_creator_ai_nickname: Opus
5.9 The nickname of the AI is just a single word model name without version, etc. 🟢 “Opus” is a single word.
5.10 The full name of the AI used to create the document is stated as “qrs_creator_ai_fullname: [qrs_creator_ai_fullname]” 🟢 qrs_creator_ai_fullname: Opus 4.8
5.11 The full name of the AI consists of the nickname and the model version number and no additional qualifier. 🟢 “Opus 4.8” has no extra qualifier.
5.12 The filename of the document is stated as “qrs_filename: [filename of this document]” 🟢 qrs_filename: beetroot_2026-0722-0328_Opus_QRS.html
5.13 All frontmatter values are trimmed: no leading/trailing whitespace, no surrounding quotes unless required by YAML. 🟢 Values are clean.

6. Page Title & Header

# Description Result Comments
6.1 [page_title] is set to the [canonical_topic] of the ER frontmatter followed by “ - Quick Reference Sheet”, HTML-entity-encoded as needed. 🟢 “Beetroot for Health & Longevity - Quick Reference Sheet”.
6.2 [header_topic] is set to the [canonical_topic] of the ER frontmatter, with HTML entities encoded as needed. 🟢 “Beetroot for Health & Longevity”.
6.3 [header_subline_date] is set to [qrs_creation_date reformatted as MM/DD/YYYY] 🟢 2026-0722 → 07/22/2026.
6.4 [header_subline_model] is set to [qrs_creator_ai_fullname] 🟢 “Opus 4.8”.
6.5 No additional header content appears: no badge, version stamp, AKA / alternate names line, source-AI attribution, audit date, or QRS variant marker. 🟢 Header carries only the standard subline.

7. At-A-Glance Section

# Description Result Comments
7.1 [at_a_glance] is dense, execution-oriented summary of the ER Conclusion section 🟢 Condenses the Conclusion faithfully.
7.2 [at_a_glance] is no longer than 60 words 🟢 58 words.
7.3 Every fact in [at_a_glance] is supported by a distinct passage in the ER. 🟢 Each claim traces to the Conclusion.
7.4 It DOES NOT use acronyms or technical classifications that require specialist knowledge, uses plain-language terms instead 🟢 “relaxes and widens blood vessels” rather than jargon.
7.5 It DOES NOT cite specific trials (names, years, sample sizes, p-values) 🟢 No trial citations.
7.6 It DOES NOT cite effect sizes, relative risks, or statistical results 🟢 No statistics.

8. Contraindications

# Description Result Comments
8.1 The section is derived from the ER Key Interactions & Contraindications section 🟢 Sourced from the ER avoid/caution populations (line 313).
8.2 [stop_items] represent the Contraindications from the ER 🟢 Low BP, advanced CKD, oxalate-stone history.
8.3 Individual [stop_items] are formatted as <li></li> 🟢 Each item is an <li>.
8.4 Items are as concise as possible. No trailing explanations, elaborations, rationale, attributions, citations, study details, or content after a dash. 🟢 Clean key facts, no trailing clauses.
8.5 Parenthetical qualifiers from the ER bullet are preserved as part of the item, kept concise. 🟢 “(Stage 4–5 CKD)” preserved.
8.6 When the ER uses ranking notation inside parens (e.g., “>” for severity ordering) that depends on an explanatory phrase, normalize to a plain comma-separated list. N/A The ER contraindication bullets use no ranking notation.
8.7 If no [stop_items] are present the section is left empty N/A Stop items are present.

9. Key Interactions

# Description Result Comments
9.1 The section is derived from the ER Key Interactions & Contraindications section 🟢 Sourced from the ER interactions bullets.
9.2 [caution_items] represent the Key Interactions from the ER, excluding any already listed as Contraindications 🟢 BP meds, nitrates, PDE5, NSAIDs/antacids, NO supplements, mouthwash; no overlap with contraindications.
9.3 Individual [caution_items] are formatted as <li></li> 🟢 Each item is an <li>.
9.4 Items are as concise as possible. No trailing explanations, elaborations, rationale, attributions, citations, study details, or content after a dash. 🟢 Clean facts, no trailing clauses.
9.5 Parenthetical qualifiers (example drug lists, etc.) ARE preserved as part of the item, kept concise. 🟢 Example drug lists preserved for each class.
9.6 When the ER uses ranking notation inside parens, normalize to a plain comma-separated list. N/A The ER interaction bullets use no ranking notation.
9.7 If no [caution_items] are present the section is left empty N/A Caution items are present.

10. Protocol

# Description Result Comments
10.1 The section is derived from the ER Protocol section 🟢 Dose/regimen/timing derive from the ER Therapeutic Protocol.
10.2 The three sets of [action] items cover the three most important actionable implementation aspects from the ER Protocol section 🟢 Standard dose, regimen, timing.
10.3 If less than three distinct actionable implementation aspects are mentioned in the ER the unused sets are left empty and made invisible. N/A Three actionable aspects are present.
10.4 All used [action_#label], [action#value], [action#_sub] items are filled with meaningful content derived from the ER Protocol section. 🟢 All three sets are fully and meaningfully populated.

11. Time to Effect

# Description Result Comments
11.1 The three sets of [time] items cover the three most important time-to-effect aspects from the ER 🟢 BP acute, BP sustained, performance.
11.2 The sets are picked and ordered by the magnitude of the related benefit 🟢 Blood pressure (best-supported) precedes performance.
11.3 If less than three distinct time-to-effect aspects are mentioned in the ER the unused sets are left empty and made invisible. N/A Three time-to-effect aspects are present.
11.4 All used [time_#label], [time#value], [time#_sub] items are filled with meaningful content derived from the ER. 🟢 All three sets are populated from ER Practical Considerations.
11.5 If the ER does not provide any information on time to effect, the section is removed completely from the Protocol Panel N/A The ER provides time-to-effect information.

12. Benefits

# Description Result Comments
12.1 The section is derived from the ER Expected Benefits section 🟢 Tiers mirror the ER Expected Benefits.
12.2 Key variables are [benefits_high], [benefits_medium], [benefits_low], [benefits_speculative] 🟢 All four tier variables populated.
12.3 Items are as concise as possible. No explanations, elaborations, effect sizes, qualifiers, attributions, citations, study details, mechanistic explanations. 🟢 Short key facts only.
12.4 Parenthetical content — including effect sizes, sample notes, mechanistic hints, example studies — is stripped, NOT preserved. 🟢 “(Blood-Vessel Lining)” stripped from endothelial function.
12.5 If no items of a specific sub-section are present the respective SPAN is set to “display=none”. N/A All four tiers contain items.

13. Risks

# Description Result Comments
13.1 The section is derived from the ER Potential Risks & Side Effects section 🟢 Tiers mirror the ER Risks section.
13.2 Key variables are [risks_high], [risks_medium], [risks_low], [risks_speculative] 🟢 All four tier variables populated.
13.3 Items are as concise as possible. No explanations, elaborations, effect sizes, qualifiers, attributions, citations, study details, mechanistic explanations. 🟢 Short key facts only.
13.4 Parenthetical content — including frequencies, severity grades, sample notes, mechanistic hints, example studies — is stripped, NOT preserved. 🟢 “(Hypotension)” and “(Oxalate)” stripped.
13.5 If no items of a specific sub-section are present the respective SPAN is set to “display=none”. N/A All four tiers contain items.

14. Monitoring

# Description Result Comments
14.1 The section is derived from the ER Monitoring section 🟢 Table derives from ER Monitoring Protocol.
14.2 All measurable/quantifiable biomarkers from the Monitoring section are listed 🟢 All five ER biomarkers listed with targets.
14.3 [monitoring_cadence] is populated with the monitoring cadence/frequency derived from the ER Monitoring section. 🟢 Cadence text matches the ER.

15. Qualitative Assessment

# Description Result Comments
15.1 The section is derived from the ER Monitoring section 🟢 Qualitative markers derive from the ER Monitoring section.
15.2 All subjective/qualitative biomarkers from the Monitoring section are listed 🟢 All four qualitative markers listed.

Issues 22/07/2026 05:08

Pass rate 100.00%. No issues found.